Printer Friendly

Japan Science and Technology obtains United States patent.

Japan Science and Technology Corporation (Saitama, Japan) has patented mesophilic methane bacteria obtained from digested sludge are acclimatized in an H2/CO2 medium and the acclimatized methane bacteria are grown on a support inclusive of inorganic nutritional salts of trace metal elements by using an immobilized bed bioreactor. The grown bacteria are allowed to metabolize a mixed gas, prepared by adding hydrogen to at least one of coal gas and biogas, into methane and at the same time, cobalamin contained in the fermented liquor is recovered as an extracellular product in the form of cyanocobalamin by using potassium cyanide to thereby produce vitamin B12 efficiently in a high content and high yield. (US 6,972,188)
COPYRIGHT 2005 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:for mesophilic methane bacteria
Publication:BIOTECH Patent News
Article Type:Brief Article
Geographic Code:9JAPA
Date:Dec 1, 2005
Previous Article:Department of Health and Human Services obtains United States patent.
Next Article:Rigel granted patents in immunology, virology and oncology.

Related Articles
Japan Science and Technology obtains United States patent.
MorphoSys widens scope of United States patent for HuCAL technology.
NanoLogix files hydrogen production provisional patent application expanding intellectual property portfolio to 32 patents issued and pending in...
Biocoral obtains Japanese patent for osteoblast differentiation.
Noveko announces antimicrobial masks and filters manufactured according to patented technology.
GangaGen granted new United States patent on therapeutic bacteriophages.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters